NANETTE PETTRY: Open Payments
NPI 1326062845 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,735 in 73 payments from 11 companies in 2025. Trend: 2023 $2,403 · 2024 $6,622 · 2025 $2,735
Food & beverage: $2,241Speaker / faculty: $410Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $648 |
| Phathom Pharmaceuticals, Inc. | 4 | $447 |
| Madrigal Pharmaceuticals | 6 | $390 |
| Janssen Biotech, Inc. | 11 | $380 |
| Ardelyx, Inc. | 6 | $286 |
| Aimmune Therapeutics, Inc. | 11 | $196 |
| Enterra Medical, Inc. | 1 | $160 |
| Novo Nordisk Inc | 1 | $119 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
Products named: VOQUEZNA, SKYRIZI, REZDIFFRA, TREMFYA, IBSRELA, ZENPEP, Wegovy, RINVOQ.
Industry payments across TX — which companies pay providers there.
